Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		93 Months Ended
	Jul. 31, 2013	Jul. 31, 2012	Jul. 31, 2013
Cash flows from operating activities:
Net loss	$ (839,867)	$ (927,431)	$ (18,442,147)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	37,766	24,715	214,139
Gain on extinguishment of debt		(273,371)	(288,192)
Change in value of derivatives	(2,311)	(55,195)	151,615
Amortization of costs and fees related to convertible debentures	11,798	232,656	1,018,106
Common stock issued for services			2,144,790
Common stock issued to officers, directors and consultants for services	993	112,796	3,212,484
Common stock issued for shares of subsidiary stock			254,000
Common stock of subsidiary issued to employees and consultants			2,815
Common stock issued as a commission			3,000
Common stock issued for accounts payable			296,583
Common stock issued to former licensee			41,319
Common stock issued/recovered on cancelled agreements			20,478
Non-cash compensation for stock options and warrants			631,923
Costs and fees related to issuance of convertible debt		3,288	542,540
Interest expense related to beneficial conversion feature	(1,980)		1,942,820
Interest paid with common stock			118,487
Interest on notes receivable for common stock			(1,373)
(Increase) decrease in assets:
Related party receivables	15,269
Prepaid expenses	26,400	(29,138)	20,871
Inventories	(41,887)	(25,600)	(143,275)
Increase (decrease) in liabilities:
Trade accounts payable	161,369	(113,628)	646,263
Accounts payable to officers and directors	46,746	76,958	799,369
Accrued payroll and other expenses	106,490	150,431	540,139
Net cash used in operating activities	(479,214)	(823,519)	(6,273,246)
Cash flows from investing activities:
Purchase of fixed assets	(6,404)	(68,786)	(223,547)
Net cash used in investing activities	(6,404)	(68,786)	(223,547)
Cash flows from financing activities:
Principal payments on notes payable to stockholder	(24,400)	(84,889)	(1,297,900)
Proceeds from issuance of notes payable to a related party	17,900	60,000	1,137,700
Proceeds from issuance of notes and convertible notes payable	42,500	75,000	1,646,734
Proceeds from issuance of common stock	360,000	873,813	3,815,475
Net cash provided by financing activities	396,000	923,924	5,302,009
Net change in cash	(89,618)	31,619	(1,194,784)
Cash at beginning of period	90,132	5,206	1,195,298
Cash at end of period	514	36,825	514
Supplemental Disclosure of Cash Flow Information
Interest paid	271		11,256
Income taxes paid	1,600	1,600	21,840
Supplemental Schedule of Non-Cash Investing and Financing Activities
Conversion of convertible notes payable to shares of common stock	12,500	352,500
Common stock issued in consideration for accounts payable and accrued payroll	20,400	644,177
Notes converted by stockholders		315,500
Interest paid with common stock	1,299	126,282
Common stock issued in consideration for loan		$ 3,288